{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:09:03Z","timestamp":1778854143388,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["DRCPFA-Nov21\\u2216100001"],"award-info":[{"award-number":["DRCPFA-Nov21\\u2216100001"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C18281\/A29019"],"award-info":[{"award-number":["C18281\/A29019"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RPMI8402"],"award-info":[{"award-number":["RPMI8402"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA282701"],"award-info":[{"award-number":["R01 CA282701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA237165"],"award-info":[{"award-number":["R01 CA237165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Z505651\/1"],"award-info":[{"award-number":["MR\/Z505651\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X000095\/1"],"award-info":[{"award-number":["MR\/X000095\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000383","name":"Higher Education Funding Council for Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001317","name":"Swansea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["1386-23"],"award-info":[{"award-number":["1386-23"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.molmet.2025.102275","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:00:23Z","timestamp":1760893223000},"page":"102275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemia"],"prefix":"10.1016","volume":"102","author":[{"given":"Fernando M.","family":"Ponce-Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin R.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria D.","family":"Assmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silpita","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesh D.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric H.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Diamanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Hennequart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianna","family":"Blagih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Rouvray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Halsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ksenia","family":"Matlawska-Wasowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma E.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-5117","authenticated-orcid":false,"given":"Nicholas","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2025.102275_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41375-020-0845-6","article-title":"SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia","volume":"35","author":"Garc\u00eda-Ca\u00f1averas","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.molmet.2025.102275_bib2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/JLB.5VMR0818-330RR","article-title":"Mitochondria as emerging targets for therapies against T cell acute lymphoblastic leukemia","volume":"105","author":"Olivas-Aguirre","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.molmet.2025.102275_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141566","article-title":"RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia","volume":"131","author":"Matthijssens","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.molmet.2025.102275_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cmet.2016.03.008","article-title":"AMPK is essential to balance glycolysis and mitochondrial metabolism to control T-ALL cell stress and survival","volume":"23","author":"Kishton","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102275_bib5","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1038\/s41467-022-30396-3","article-title":"Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia","volume":"13","author":"Baran","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2025.102275_bib6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020008955","article-title":"A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia","volume":"138","author":"da Silva-Diz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.molmet.2025.102275_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2017.08.028","article-title":"Targeting metabolism for cancer therapy","author":"Luengo","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.molmet.2025.102275_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102275_bib9","series-title":"Canagliflozin, dapaliflozin and empagliflozin as monotherapies for treating type 2 diabetes (TA390)","first-page":"4","year":"2016"},{"key":"10.1016\/j.molmet.2025.102275_bib10","doi-asserted-by":"crossref","DOI":"10.1113\/jphysiol.1983.sp014903","article-title":"Possible role of calmodulin in renin secretion from isolated rat kidneys and renal cells: studies with trifluoperazine","author":"Fray","year":"1983","journal-title":"J Physiol"},{"key":"10.1016\/j.molmet.2025.102275_bib11","series-title":"Sodium-glucose linked transporter 2 (SGLT2) inhibitors in the management of type-2 diabetes: a drug class overview","author":"Mosley","year":"2015"},{"key":"10.1016\/j.molmet.2025.102275_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1646-6","article-title":"Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced \u03b2-catenin activation","author":"Hung","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.molmet.2025.102275_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-019-0203-1","article-title":"SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia","author":"Nasiri","year":"2019","journal-title":"Cancer Metabol"},{"key":"10.1016\/j.molmet.2025.102275_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat5933","article-title":"Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma","author":"Scafoglio","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.molmet.2025.102275_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112864","article-title":"Impact of anti-diabetic sodium-glucose cotransporter 2 inhibitors on tumor growth of intractable hematological malignancy in humans","volume":"149","author":"Nakachi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.molmet.2025.102275_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchf.2023.10.005","article-title":"SGLT2 inhibitors in patients with cancer therapy-related cardiotoxicity: an unexpected benefit?","volume":"12","author":"Oren","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.molmet.2025.102275_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchf.2023.08.026","article-title":"SGLT2 inhibitor use and risk of clinical events in patients with cancer therapy\u2013related cardiac dysfunction","volume":"12","author":"Avula","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.molmet.2025.102275_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117278","article-title":"Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway","volume":"178","author":"Mattii","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.molmet.2025.102275_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106949","article-title":"Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: a potential rescue strategy","volume":"142","author":"Madonna","year":"2022","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.molmet.2025.102275_bib20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.molmet.2025.102275_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154754","article-title":"Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling","volume":"133","author":"Ding","year":"2023","journal-title":"J Clin Investig"},{"key":"10.1016\/j.molmet.2025.102275_bib22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s42003-023-05289-w","article-title":"The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy","volume":"6","author":"Ali","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.molmet.2025.102275_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41419-018-0273-y","article-title":"Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect","volume":"9","author":"Secker","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.molmet.2025.102275_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbabio.2008.11.003","article-title":"Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species","volume":"1787","author":"Fato","year":"2009","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"10.1016\/j.molmet.2025.102275_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.902117","article-title":"Current use of asparaginase in acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"10","author":"Maese","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.molmet.2025.102275_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/leu.2017.283","article-title":"High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG","volume":"32","author":"Sakura","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.molmet.2025.102275_bib27","article-title":"Metabolic determinants of cellular fitness dependent on mitochondrial reactive oxygen species","volume":"6","author":"Kong","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.molmet.2025.102275_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.05.001","article-title":"Canagliflozin impairs T-cell effector function via metabolic suppression in autoimmunity","author":"Jenkins","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102275_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140019","article-title":"Canagliflozin extends life span in genetically heterogeneous male but not female mice","volume":"5","author":"Miller","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102275_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41568-022-00543-5","article-title":"Acetyl-CoA metabolism in cancer","volume":"23","author":"Guertin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.molmet.2025.102275_bib31","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/bloodadvances.2024013762","article-title":"ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development","volume":"9","author":"Andrieu","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.molmet.2025.102275_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2025.100069","article-title":"A feedforward loop between ACLY and MYC supports T-ALL progression in vivo","volume":"2","author":"da Silva-Diz","year":"2025","journal-title":"Blood Neoplasia"},{"issue":"1 10","key":"10.1016\/j.molmet.2025.102275_bib33","first-page":"1","article-title":"Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells","volume":"10","author":"Kampen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2025.102275_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148550","article-title":"Clinical development of metabolic inhibitors for oncology","volume":"132","author":"Lemberg","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.molmet.2025.102275_bib35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41467-020-20223-y","article-title":"Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy","volume":"12","author":"Tajan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2025.102275_bib36","article-title":"Cycling back to folate metabolism in cancer","author":"Lee","year":"2024","journal-title":"Nat Cancer"},{"key":"10.1016\/j.molmet.2025.102275_bib37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature22056","article-title":"Modulating the therapeutic response of tumours to dietary serine and glycine starvation","volume":"544","author":"Maddocks","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102275_bib38","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nm.3955","article-title":"Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia","volume":"21","author":"Herranz","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102275_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bjh.12727","article-title":"Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia","volume":"165","author":"Samuels","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.molmet.2025.102275_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","article-title":"The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo","volume":"42","author":"Blagih","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmet.2025.102275_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molcel.2015.08.013","article-title":"Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth","volume":"60","author":"Vincent","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.molmet.2025.102275_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002309","article-title":"Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis","volume":"13","author":"Griss","year":"2015","journal-title":"PLoS Biol"},{"key":"10.1016\/j.molmet.2025.102275_bib43","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1073\/pnas.1312570111","article-title":"Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1\u03b1","volume":"111","author":"Faubert","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.molmet.2025.102275_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2049-3002-1-22","article-title":"PGC-1\u03b1 supports glutamine metabolism in breast cancer","volume":"1","author":"McGuirk","year":"2013","journal-title":"Cancer Metabol"},{"key":"10.1016\/j.molmet.2025.102275_bib45","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cmet.2022.07.012","article-title":"Carbon source availability drives nutrient utilization in CD8+ T cells","volume":"34","author":"Kaymak","year":"2022","journal-title":"Cell Metab"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:23:35Z","timestamp":1778851415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877825001826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"alternative-id":["S2212877825001826"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102275","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemia","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102275"}}